Poster Session II - A279 DISTINCT CLINICAL AND PATHOLOGIC CHARACTERISTCIS OF UC-ASSOCIATED NEOPLASIA AMONG PATIENTS UNDERGOING COLECTOMY: A 15-YEAR SINGLE-CENTRE COHORT STUDY

Abstract Background Despite advancements in endoscopic surveillance approaches and medical therapies, ulcerative colitis (UC)-associated neoplasia remains a major concern in patient care and often necessitates colectomy. Aims This study aimed to compare the clinical characteristics of patients with UC-associated neoplasia with those of medically refractory UC who underwent colectomy, and to further characterize the pathological features of UC-associated neoplasia. Methods We retrospectively reviewed medical records of patients with UC who underwent colectomy between January 2010 to July 2024. Patients were categorized as having medically refractory disease (MR) or UC-associated neoplasia as their indication for colectomy. Clinicopathological characteristics were compared between groups, and multivariate logistic regression was performed to identify factors associated with colectomy indications. Results A total of 486 patients were eligible for analysis, comprising 356 (73.6%) with MR and 130 (26.7%) with UC-associated neoplasia. Patients in the neoplasia group were older at colectomy (median 47 vs 34 years, p < 0.001) and had a longer disease duration (16 vs 4 years, p < 0.001). In multivariate analysis, concurrent steroid use was ten times more likely in the MR group (Odds ratio [OR] 10.1, 95% confidence interval [CI] 3.9-28.8, p < 0.001), while PSC was ten times more likely in the neoplasia group (OR 0.1, 95% CI 0.05-0.20, p < 0.001). In the neoplasia group, 44.8% had neoplasia in 2 or more colonic segments and 67.7% showed advanced lesions including high-grade dysplasia or adenocarcinoma. When comparing the most advanced findings in preoperative biopsies compared with surgical pathology, 31.9% (37/116) showed discordant findings. Among these, 42.1% (16/38) with low-grade dysplasia and 25.7% (9/35) with high-grade dysplasia on biopsy were found to have more advanced lesions in the colectomy specimens. Conclusions Significantly longer disease duration and a high rate of PSC were observed in patents with UC-associated neoplasia. Most neoplasia cases exhibited histologically active inflammation in surgical specimens, and a substantial portion showed multifocal or advanced lesions, Notably, over one-third of patients with dysplasia on biopsy had more advanced pathology at colectomy. These findings underscore the importance of meticulous endoscopic and histologic surveillance in long-standing UC even in presence of active inflammation. Funding Agencies NIH, NIDDK, Hold’em for Life Charity Challenge

Authors

Institutions

Publication Details

Journal
Journal of the Canadian Association of Gastroenterology
Published
2026-02-01
DOI
https://doi.org/10.1093/jcag/gwaf042.278
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Poster Session II - A279 DISTINCT CLINICAL AND PATHOLOGIC CHARACTERISTCIS OF UC-ASSOCIATED NEOPLASIA AMONG PATIENTS UNDERGOING COLECTOMY: A 15-YEAR SINGLE-CENTRE COHORT STUDY

Krzysztof Borowski, I Hebert-milette, J Kim, J Stempak et al.
Journal of the Canadian Association of Gastroenterology
Inflammatory Bowel Disease
article

Poster Session II - A279 DISTINCT CLINICAL AND PATHOLOGIC CHARACTERISTCIS OF UC-ASSOCIATED NEOPLASIA AMONG PATIENTS UNDERGOING COLECTOMY: A 15-YEAR SINGLE-CENTRE COHORT STUDY

Krzysztof Borowski, I Hebert-milette, J Kim, J Stempak, M Silverberg, J Conner, S Lee
article en

Abstract

Abstract Background Despite advancements in endoscopic surveillance approaches and medical therapies, ulcerative colitis (UC)-associated neoplasia remains a major concern in patient care and often necessitates colectomy. Aims This study aimed to compare the clinical characteristics of patients with UC-associated neoplasia with those of medically refractory UC who underwent colectomy, and to further characterize the pathological features of UC-associated neoplasia. Methods We retrospectively reviewed medical records of patients with UC who underwent colectomy between January 2010 to July 2024. Patients were categorized as having medically refractory disease (MR) or UC-associated neoplasia as their indication for colectomy. Clinicopathological characteristics were compared between groups, and multivariate logistic regression was performed to identify factors associated with colectomy indications. Results A total of 486 patients were eligible for analysis, comprising 356 (73.6%) with MR and 130 (26.7%) with UC-associated neoplasia. Patients in the neoplasia group were older at colectomy (median 47 vs 34 years, p < 0.001) and had a longer disease duration (16 vs 4 years, p < 0.001). In multivariate analysis, concurrent steroid use was ten times more likely in the MR group (Odds ratio [OR] 10.1, 95% confidence interval [CI] 3.9-28.8, p < 0.001), while PSC was ten times more likely in the neoplasia group (OR 0.1, 95% CI 0.05-0.20, p < 0.001). In the neoplasia group, 44.8% had neoplasia in 2 or more colonic segments and 67.7% showed advanced lesions including high-grade dysplasia or adenocarcinoma. When comparing the most advanced findings in preoperative biopsies compared with surgical pathology, 31.9% (37/116) showed discordant findings. Among these, 42.1% (16/38) with low-grade dysplasia and 25.7% (9/35) with high-grade dysplasia on biopsy were found to have more advanced lesions in the colectomy specimens. Conclusions Significantly longer disease duration and a high rate of PSC were observed in patents with UC-associated neoplasia. Most neoplasia cases exhibited histologically active inflammation in surgical specimens, and a substantial portion showed multifocal or advanced lesions, Notably, over one-third of patients with dysplasia on biopsy had more advanced pathology at colectomy. These findings underscore the importance of meticulous endoscopic and histologic surveillance in long-standing UC even in presence of active inflammation. Funding Agencies NIH, NIDDK, Hold’em for Life Charity Challenge

Journal of the Canadian Association of GastroenterologyVol. 9(Supplement_1)
Mount Sinai Hospital (CA)
Openalex Percentile: Top 54%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.